Drug intelligence / Profile preview

tigogenin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal, Topical, Rectal
01

Overview

Tigogenin is a steroidal sapogenin, a natural product structurally related to diosgenin and hecogenin, found in various plants such as *Agave* and *Yucca* species. Research has demonstrated that tigogenin possesses antiproliferative and proapoptotic properties, particularly in the context of inflammatory joint diseases like rheumatoid arthritis (RA). It induces apoptosis in human RA fibroblast-like synoviocytes (FLS) through a caspase-dependent mechanism that involves the activation of the p38 mitogen-activated protein kinase (MAPK) pathway. Interestingly, tigogenin-induced apoptosis is also associated with the upregulation of cyclooxygenase-2 (COX-2) and increased production of prostaglandin E2 (PGE2). While it shows potential as a therapeutic agent for RA, it is currently primarily utilized as a research tool and as a precursor in the semi-synthesis of steroid hormones.

Other names
(3beta,5alpha,25R)-Spirostane-3-olTigogenine(5alpha,25R)-spirostan-3beta-ol
02

Targets

CASP3 (Caspase-3)CASP9 (Caspase-9)MAPK14 (p38 mitogen-activated protein kinase alpha)CASP8 (Caspase-8)

Beyond the preview

Go deeper on tigogenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tigogenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call